Zdrowie i gospodarka · 21/11/2014
FDA Announces Final Guidance for Biological Products: Human Blood and Blood Components
The FDA has released a final guidance document providing recommendations for manufacturers of licensed whole blood and blood components, including submission procedures and labeling changes, to finalize an approved biologics license application.